Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/8/2017
SIETES contiene 91969 citas

 
 
 1 a 20 de 174 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Nair NP, Chalmers L, Bereznicki BJ, Curtain C, Peterson GM, Connolly M, Bereznicki LR. Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional study in two Tasmanian hospitals. Drug Saf 2017;40:597-606. [Ref.ID 101969]
4. Cita con resumen
Young K. Who might benefit from long-term DAPT? Risk score may help . Journal Watch 2015:1. [Ref.ID 99636]
6. Cita con resumen
McCallum PK, Mathur R, Hull SA, Saja K, Green L, Morris JK, Ashman N. Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation: a cross-sectional study. BMJ Open 2013;3:e003343. [Ref.ID 96277]
7.Tiene citas relacionadas
Ingelfinger JR, Marsden PA. Estimated GFR and risk of death - Is cystatin C useful?. N Engl J Med 2013;369:974-5. [Ref.ID 96071]
8.Tiene citas relacionadas Cita con resumen
Shlipak MG, Mathushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT, for the CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013;369:932-43. [Ref.ID 96070]
9. Cita con resumen
Maccallum PK, Mathur R, Hull SA, Saja K, Green L, Morris JK, Ashman N. Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation: a cross-sectional study. BMJ Open 2013;3:27 de septiembre. [Ref.ID 96036]
11.Tiene citas relacionadas Cita con resumen
Roldán V, Marín F, Fernández H, Manzano-Fernández S, Gallego P, Valdés M, Vicente V, Lip GYH. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real world" population with atrial fibrillation receiving anticoagulant therapy. Chest 2013;143:179-84. [Ref.ID 94638]
12. Cita con resumen
Anónimo. New NICE guideline for ostoporosis: tools for fragility fracture risk assessment. Drug Ther Bull 2012;50:110-1. [Ref.ID 93821]
13.Tiene citas relacionadas Cita con resumen
Donzé J, Rodondi N, Waeber G, Monney P, Cornuz J, Aujesky D. Scores to predict major bleeding risk during oral anticoagulation therapy: a prospective validation study. Am J Med 2012;125:1095-102. [Ref.ID 93713]
15. Cita con resumen
Early A, Miskulin D, Lamb EJ, Levey AS, Uhlig K. Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med 2012;156:785-95. [Ref.ID 93110]
16. Cita con resumen
Tognoni G. Appunti per vivere -ragionevolmente?- tempi irragionevoli. Informazioni sui Farmaci 2011;35:61-2. [Ref.ID 91700]
17. Cita con resumen
Díez-Manglano J, López-García F, Barquero-Romero J, Galofré-Alvaro N, Montero-Rivas L, Almagro-Mena P, Soriano JB, en nombre de los investigadores del estudio ECCO y del Grupo de Enfermedad Pulmonar Obstructiva Crónica de la Sociedad Española de Medicina Interna. Riesgo de fractura osteoporótica y de cadera en pacientes con enfermedad pulmonar obstructiva crónica. Rev Clin Esp 2011;211:443-9. [Ref.ID 91559]
18. Cita con resumen
19.Tiene citas relacionadas Cita con resumen
Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Willinska ME, Evans ML. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ 2011;342:906. [Ref.ID 90482]
20.Tiene citas relacionadas Cita con resumen
Kovatchev B. Closed loop control for type 1 diabetes. BMJ 2011;342:883-4. [Ref.ID 90474]
Seleccionar todas
 
 1 a 20 de 174 siguiente >>